Kolle Gesche, Metterlein Thomas, Gruber Michael, Seyfried Timo, Petermichl Walter, Pfaehler Sophie-Marie, Bitzinger Diane, Wittmann Sigrid, Bredthauer Andre
Department of Anesthesiology, University Medical Centre Regensburg, Regensburg 93053, Germany.
Department of Anesthesiology, Klinikum Ansbach, Ansbach 91522, Germany.
J Inflamm Res. 2021 Jan 6;14:1-12. doi: 10.2147/JIR.S275525. eCollection 2021.
Local anesthetics (LAs) are frequently used during anesthesia; however, they may influence granulocyte function which in turn could modify immune responses in the perioperative period. Therefore, the aim of this study was to investigate the impact of clinically used doses of bupivacaine and lidocaine on granulocyte function with regard to migration, reactive oxygen species (ROS) production, neutrophil extracellular traps (NETosis) formation, and viability.
A total of 38 granulocyte-enriched samples from healthy subjects were obtained by whole blood lysis. Polymorphonuclear neutrophil (PMN) samples were incubated simultaneously with different concentrations of either bupivacaine (0.03-3.16 mmol/L) or lidocaine (0.007-14.21 mmol/L), or without drug (control). Live cell imaging was conducted in order to observe granulocyte chemotaxis, migration, ROS production, and NETosis. Flow cytometry was used to analyze viability and antigen expression.
The track length (TL) of PMNs exposed to bupivacaine concentrations of 0.16 mmol/L and above significantly decreased compared to the control. Low concentrations of lidocaine were associated with slight but significant increases in TL, whereas this changed with concentrations above 1.4 mmol/L, showing a significant decrease in TL. PMN incubated with bupivacaine concentrations of 1.58 mmol/L and above or lidocaine concentrations of at least 3.6 mmol/L showed no migration or chemotaxis at all. Time to onset of maximal ROS production and time for half-maximal NETosis decreased in a dose-dependent manner for both substances. Equipotency in NETosis induction was reached by bupivacaine (1.1 mmol/L) at significantly lower concentrations than lidocaine (7.96 mmol/L). Cell viability and oxidative burst were unaffected by LAs.
Local anesthetics in clinically used doses ameliorate granulocyte defense mechanisms, thus indicating their potentially decisive effect during the perioperative period.
局部麻醉药(LAs)在麻醉过程中经常使用;然而,它们可能会影响粒细胞功能,进而可能改变围手术期的免疫反应。因此,本研究的目的是探讨临床使用剂量的布比卡因和利多卡因对粒细胞功能在迁移、活性氧(ROS)产生、中性粒细胞胞外陷阱(NETosis)形成和活力方面的影响。
通过全血裂解从健康受试者中获得总共38个富含粒细胞的样本。多形核中性粒细胞(PMN)样本同时与不同浓度的布比卡因(0.03 - 3.16 mmol/L)或利多卡因(0.007 - 14.21 mmol/L)或无药物(对照)一起孵育。进行活细胞成像以观察粒细胞趋化性、迁移、ROS产生和NETosis。使用流式细胞术分析活力和抗原表达。
与对照相比,暴露于0.16 mmol/L及以上布比卡因浓度的PMN的轨迹长度(TL)显著降低。低浓度的利多卡因与TL略有但显著增加相关,而当浓度高于1.4 mmol/L时这种情况发生变化,TL显著降低。与1.58 mmol/L及以上布比卡因浓度或至少3.6 mmol/L利多卡因浓度孵育的PMN根本没有迁移或趋化性。两种物质最大ROS产生的起始时间和NETosis达到最大值一半的时间均呈剂量依赖性降低。布比卡因(1.1 mmol/L)在显著低于利多卡因(7.96 mmol/L)的浓度下达到诱导NETosis的等效性。细胞活力和氧化爆发不受局部麻醉药影响。
临床使用剂量的局部麻醉药改善了粒细胞防御机制,从而表明它们在围手术期可能具有决定性作用。